Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Boehringer buys into oncolytic viruses via €210m ViraTherapeutics deal

Option to acquire the Austrian biotech after phase I trials remains open to Boehringer 

- PMLiVE

The global scourge of counterfeit medicines

Pharmaceuticals are a prime target for organised crime

- PMLiVE

Merck KGaA appoints chief strategy officer

Isabel De Paoli will take up the role from 1 October

China flag thumb

China: Smoking prevalence greater in men while women kick habit

New study also finds the number of cigarettes smoked daily has risen

- PMLiVE

Sandoz seeks mobile-enabled health access solutions

Launches global competition inviting submissions via Facebook

- PMLiVE

Transformational technology

Big data, the cloud and the value of insights

- PMLiVE

NICE backs Bayer’s Eylea as first-line BRVO treatment

Recommends visual impairment therapy over current laser treatment

- PMLiVE

Iris Pauporté joins OSE Immunotherapeutics

She becomes clinical project director at the French biotech

Shire Basingstoke

Shire gives up on Momenta-partnered Humira biosimilar

Will fund programme for another 12 months while divesting ongoing activities to Momenta

- PMLiVE

Amgen’s Kyprolis scarred by head-to-head duel with Velcade

Failed to show superior progression-free survival in first-line treatment trials

- PMLiVE

Is there an ROI on KOLs?

Can you measure return on investment (ROI) from compliant, patient-centred skills training for key opinion leaders?

- PMLiVE

Grünenthal research consortium receives €1.5m EU grant

Wins funding for development of efficacy testing in neuropathic pain treatments

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links